Lyme Arthritis Treatment Guidelines
Introduction to Lyme Arthritis Treatment
- The American College of Physicians recommends a 30-day course of doxycycline specifically for Lyme arthritis, as this is the only established indication requiring this extended duration 1
- The Infectious Diseases Society of America recommends doxycycline 100 mg twice daily for 28 days (often rounded to 30 days in practice) as the first-line oral therapy for patients with Lyme arthritis without neurologic involvement 1
Treatment Regimens
- For children ≥8 years with Lyme arthritis, the Centers for Disease Control and Prevention recommends doxycycline at 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) for 28 days 1, 2
- The evidence strongly supports a 28-day course of doxycycline, which has been validated in clinical trials showing resolution of arthritis in 18 of 20 evaluable patients treated with this regimen 1
Administration and Safety Guidelines
- When prescribing 30 days of doxycycline for Lyme arthritis, patients should take the medication with 8 ounces of fluid to reduce esophageal irritation, with food to minimize gastrointestinal intolerance, and avoid sun exposure due to photosensitivity risk 3, 4
- Doxycycline is contraindicated in pregnancy, lactation, and children <8 years 3
Treatment of Persistent Arthritis
- If arthritis persists after the 28-30 day course, the Infectious Diseases Society of America recommends considering a second 4-week course of oral antibiotics before escalating to intravenous ceftriaxone 5
- Reserve IV therapy for patients who fail two courses of oral therapy or have PCR-confirmed persistent infection 6, 7
Oral Doxycycline Regimen for Lyme Arthritis
Treatment Regimen
- Oral doxycycline 100 mg twice daily for a 28‑day course (often rounded to 30 days) is the appropriate first‑line therapy for Lyme arthritis in adults with normal renal function, no tetracycline allergy, and who are not pregnant. 8
- In a clinical trial, arthritis resolved in 18 of 20 patients receiving this doxycycline regimen, supporting its efficacy. 8
Pre‑Treatment Neurologic Assessment
- Prior to initiating oral therapy, patients must be screened for neurologic involvement (e.g., distal paresthesias, memory changes, radiculopathy, meningeal signs); presence of any neurologic symptoms mandates parenteral ceftriaxone 2 g daily for 14–28 days instead of oral doxycycline. 8
- Patients with isolated arthralgia without objective arthritis or neurologic findings can be managed with the standard oral doxycycline regimen. 8
Management of Persistent or Refractory Arthritis
- A subset of patients may develop antibiotic‑refractory arthritis that requires symptomatic management rather than additional antibiotic courses. 8